• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The -258A/G (SNP rs12885300) polymorphism of the human type 2 deiodinase gene is associated with a shift in the pattern of secretion of thyroid hormones following a TRH-induced acute rise in TSH.人类 2 型脱碘酶基因的-258A/G(SNP rs12885300)多态性与 TSH 受 TRH 诱导的急性升高后甲状腺激素分泌模式的改变有关。
Eur J Endocrinol. 2012 May;166(5):839-45. doi: 10.1530/EJE-11-1073. Epub 2012 Feb 3.
2
The Thr92Ala 5' type 2 deiodinase gene polymorphism is associated with a delayed triiodothyronine secretion in response to the thyrotropin-releasing hormone-stimulation test: a pharmacogenomic study.该 Thr92Ala 5' 型 2 脱碘酶基因多态性与促甲状腺激素释放激素刺激试验后三碘甲状腺原氨酸分泌延迟有关:一项药物基因组学研究。
Thyroid. 2010 Dec;20(12):1407-12. doi: 10.1089/thy.2010.0244. Epub 2010 Nov 7.
3
The type 2 deiodinase ORFa-Gly3Asp polymorphism (rs12885300) influences the set point of the hypothalamus-pituitary-thyroid axis in patients treated for differentiated thyroid carcinoma.2 型脱碘酶 ORFa-Gly3Asp 多态性(rs12885300)影响分化型甲状腺癌患者下丘脑-垂体-甲状腺轴的设定点。
J Clin Endocrinol Metab. 2011 Sep;96(9):E1527-33. doi: 10.1210/jc.2011-0235. Epub 2011 Jun 29.
4
Association between phenols and thyroid hormones: The role of iodothyronine deiodinase genes.酚类物质与甲状腺激素的关系:碘甲状腺原氨酸脱碘酶基因的作用。
Environ Pollut. 2022 Oct 15;311:119926. doi: 10.1016/j.envpol.2022.119926. Epub 2022 Aug 11.
5
Effects of iodine excess on serum thyrotropin-releasing hormone levels and type 2 deiodinase in the hypothalamus of Wistar rats.碘过量对 Wistar 大鼠下丘脑促甲状腺素释放激素水平和 II 型脱碘酶的影响。
Br J Nutr. 2022 Jun 14;127(11):1631-1638. doi: 10.1017/S0007114521002592. Epub 2021 Jul 12.
6
Type 2 Deiodinase Thr92Ala Polymorphism and Aging Are Associated with a Decreased Pituitary Sensitivity to Thyroid Hormone.2 型脱碘酶 Thr92Ala 多态性与衰老与垂体对甲状腺激素敏感性降低有关。
Thyroid. 2023 Mar;33(3):294-300. doi: 10.1089/thy.2022.0472. Epub 2023 Feb 13.
7
Effects of maternal nicotine exposure on thyroid hormone metabolism and function in adult rat progeny.母体尼古丁暴露对成年大鼠后代甲状腺激素代谢及功能的影响。
J Endocrinol. 2015 Mar;224(3):315-25. doi: 10.1530/JOE-14-0473. Epub 2015 Feb 4.
8
Hypothalamic-pituitary thyroid axis alterations in female mice with deletion of the neuromedin B receptor gene.神经降压素B受体基因缺失的雌性小鼠下丘脑-垂体-甲状腺轴改变
Regul Pept. 2014 Nov;194-195:30-5. doi: 10.1016/j.regpep.2014.10.002. Epub 2014 Oct 24.
9
Thyroxine-induced expression of pyroglutamyl peptidase II and inhibition of TSH release precedes suppression of TRH mRNA and requires type 2 deiodinase.甲状腺素诱导的焦谷氨酸肽酶 II 的表达和 TSH 释放的抑制先于 TRH mRNA 的抑制,并且需要 II 型脱碘酶。
J Endocrinol. 2011 Oct;211(1):73-8. doi: 10.1530/JOE-11-0248. Epub 2011 Jul 25.
10
Common genetic variations of deiodinase genes and prognosis of brain tumor patients.脱碘酶基因的常见遗传变异与脑瘤患者的预后。
Endocrine. 2019 Dec;66(3):563-572. doi: 10.1007/s12020-019-02016-6. Epub 2019 Aug 26.

引用本文的文献

1
Thyroid Hormone Pathways in Respiratory Diseases: Mechanism and Therapeutic Potential.呼吸系统疾病中的甲状腺激素信号通路:机制与治疗潜力
J Inflamm Res. 2025 Aug 4;18:10519-10531. doi: 10.2147/JIR.S529790. eCollection 2025.
2
Current Understanding of Human Polymorphism in Selenoprotein Genes: A Review of Its Significance as a Risk Biomarker.当前对人类硒蛋白基因多态性的认识:作为风险生物标志物的意义综述。
Int J Mol Sci. 2024 Jan 24;25(3):1402. doi: 10.3390/ijms25031402.
3
The Physiological Functions and Polymorphisms of Type II Deiodinase.Ⅱ型脱碘酶的生理功能及多态性。
Endocrinol Metab (Seoul). 2023 Apr;38(2):190-202. doi: 10.3803/EnM.2022.1599. Epub 2023 Apr 27.
4
Critical Approach to Hypothyroid Patients With Persistent Symptoms.对持续存在症状的甲状腺功能减退症患者的批判性方法。
J Clin Endocrinol Metab. 2023 Sep 18;108(10):2708-2716. doi: 10.1210/clinem/dgad224.
5
Combination Therapy for Hypothyroidism: Rationale, Therapeutic Goals, and Design.甲状腺功能减退症的联合治疗:原理、治疗目标和设计。
Front Endocrinol (Lausanne). 2020 Jul 8;11:371. doi: 10.3389/fendo.2020.00371. eCollection 2020.
6
Targeting the right population for T3 + T4 combined therapy: where are we now and where to next?确定T3+T4联合治疗的合适人群:我们目前的情况及下一步方向?
Endocrine. 2020 Aug;69(2):244-248. doi: 10.1007/s12020-020-02391-5. Epub 2020 Jun 22.
7
A study of the role of DIO1 and DIO2 polymorphism in thyroid cancer and drug response to therapy in the Saudi population.一项关于沙特人群中DIO1和DIO2基因多态性在甲状腺癌及治疗药物反应中的作用的研究。
Saudi Pharm J. 2019 Sep;27(6):841-845. doi: 10.1016/j.jsps.2019.05.005. Epub 2019 May 21.
8
Study of Deiodinase Type 2 Polymorphisms in Graves' Disease and Ophthalmopathy in a Swedish Population.瑞典人群中Graves病和眼病患者2型脱碘酶多态性的研究
Eur Thyroid J. 2018 Nov;7(6):289-293. doi: 10.1159/000490892. Epub 2018 Jul 20.
9
Hypothyroid Patients Encoding Combined MCT10 and DIO2 Gene Polymorphisms May Prefer L-T3 + L-T4 Combination Treatment - Data Using a Blind, Randomized, Clinical Study.编码MCT10和DIO2基因多态性的甲状腺功能减退患者可能更适合左甲状腺素钠(L-T3)+左旋甲状腺素(L-T4)联合治疗——一项采用盲法、随机化的临床研究数据
Eur Thyroid J. 2017 Jul;6(3):143-151. doi: 10.1159/000469709. Epub 2017 Apr 24.
10
Effect of Functionally Significant Deiodinase Single Nucleotide Polymorphisms on Drinking Behavior in Alcohol Dependence: An Exploratory Investigation.功能性显著的脱碘酶单核苷酸多态性对酒精依赖患者饮酒行为的影响:一项探索性研究。
Alcohol Clin Exp Res. 2015 Sep;39(9):1665-70. doi: 10.1111/acer.12814. Epub 2015 Jul 24.

本文引用的文献

1
The Thr92Ala 5' type 2 deiodinase gene polymorphism is associated with a delayed triiodothyronine secretion in response to the thyrotropin-releasing hormone-stimulation test: a pharmacogenomic study.该 Thr92Ala 5' 型 2 脱碘酶基因多态性与促甲状腺激素释放激素刺激试验后三碘甲状腺原氨酸分泌延迟有关:一项药物基因组学研究。
Thyroid. 2010 Dec;20(12):1407-12. doi: 10.1089/thy.2010.0244. Epub 2010 Nov 7.
2
Association of the type 2 deiodinase Thr92Ala polymorphism with type 2 diabetes: case-control study and meta-analysis.2 型脱碘酶 Thr92Ala 多态性与 2 型糖尿病的关联:病例对照研究和荟萃分析。
Eur J Endocrinol. 2010 Sep;163(3):427-34. doi: 10.1530/EJE-10-0419. Epub 2010 Jun 21.
3
Association of genetic polymorphisms in the type II deiodinase gene with bipolar disorder in a subset of Chinese population.在中国人群亚组中,Ⅱ型脱碘酶基因的遗传多态性与双相情感障碍的关联。
Prog Neuropsychopharmacol Biol Psychiatry. 2009 Aug 31;33(6):986-90. doi: 10.1016/j.pnpbp.2009.05.003. Epub 2009 May 7.
4
Common variation in the DIO2 gene predicts baseline psychological well-being and response to combination thyroxine plus triiodothyronine therapy in hypothyroid patients.DIO2基因的常见变异可预测甲状腺功能减退患者的基线心理健康状况以及对甲状腺素联合三碘甲状腺原氨酸治疗的反应。
J Clin Endocrinol Metab. 2009 May;94(5):1623-9. doi: 10.1210/jc.2008-1301. Epub 2009 Feb 3.
5
Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling.脱碘酶调节甲状腺激素信号传导的细胞和分子基础。
Endocr Rev. 2008 Dec;29(7):898-938. doi: 10.1210/er.2008-0019. Epub 2008 Sep 24.
6
The role of type 1 and type 2 5'-deiodinase in the pathophysiology of the 3,5,3'-triiodothyronine toxicosis of McCune-Albright syndrome.1型和2型5'-脱碘酶在McCune-Albright综合征3,5,3'-三碘甲状腺原氨酸中毒病理生理学中的作用。
J Clin Endocrinol Metab. 2008 Jun;93(6):2383-9. doi: 10.1210/jc.2007-2237. Epub 2008 Mar 18.
7
Identification of DIO2 as a new susceptibility locus for symptomatic osteoarthritis.鉴定DIO2为症状性骨关节炎的一个新的易感基因座。
Hum Mol Genet. 2008 Jun 15;17(12):1867-75. doi: 10.1093/hmg/ddn082. Epub 2008 Mar 11.
8
Type 2 deiodinase polymorphism (threonine 92 alanine) predicts L-thyroxine dose to achieve target thyrotropin levels in thyroidectomized patients.2型脱碘酶多态性(苏氨酸92 丙氨酸)可预测甲状腺切除患者达到促甲状腺激素目标水平所需的左甲状腺素剂量。
J Clin Endocrinol Metab. 2008 Mar;93(3):910-3. doi: 10.1210/jc.2007-1067. Epub 2007 Dec 11.
9
The association of polymorphisms in the type 1 and 2 deiodinase genes with circulating thyroid hormone parameters and atrophy of the medial temporal lobe.1型和2型脱碘酶基因多态性与循环甲状腺激素参数及内侧颞叶萎缩的关联。
J Clin Endocrinol Metab. 2007 Feb;92(2):636-40. doi: 10.1210/jc.2006-1331. Epub 2006 Nov 14.
10
Studies of the common DIO2 Thr92Ala polymorphism and metabolic phenotypes in 7342 Danish white subjects.对7342名丹麦白人受试者中常见的DIO2 Thr92Ala多态性与代谢表型的研究。
J Clin Endocrinol Metab. 2007 Jan;92(1):363-6. doi: 10.1210/jc.2006-1958. Epub 2006 Oct 31.

人类 2 型脱碘酶基因的-258A/G(SNP rs12885300)多态性与 TSH 受 TRH 诱导的急性升高后甲状腺激素分泌模式的改变有关。

The -258A/G (SNP rs12885300) polymorphism of the human type 2 deiodinase gene is associated with a shift in the pattern of secretion of thyroid hormones following a TRH-induced acute rise in TSH.

机构信息

Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.

出版信息

Eur J Endocrinol. 2012 May;166(5):839-45. doi: 10.1530/EJE-11-1073. Epub 2012 Feb 3.

DOI:10.1530/EJE-11-1073
PMID:22307573
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3509195/
Abstract

OBJECTIVE

Type 2 deiodinase gene (DIO2) polymorphisms have been associated with changes in pituitary-thyroid axis homeostasis. The -258A/G (SNP rs12885300) polymorphism has been associated with increased enzymatic activity, but data are conflicting. To characterize the effects of -258A/G polymorphism on intrathyroidal thyroxine (T(4)) to triiodothyronine (T(3)) conversion and thyroid hormone (TH) secretion pattern, we studied the effects of acute, TRH-mediated, TSH stimulation of the thyroid gland.

DESIGN

Retrospective analysis.

METHODS

The TH secretion in response to 500  μg i.v. TRH injection was studied in 45 healthy volunteers.

RESULTS

Twenty-six subjects (16 females and ten males, 32.8 ± 10.4 years) were homozygous for the ancestral (-258A/A) allele and 19 (11 females and eight males, 31.1 ± 10.9 years) were carriers of the (-258G/x) variant. While no differences in the peak TSH and T(3) levels were observed, carriers of the -258G/x allele showed a blunted rise in free T(4) (FT(4); P<0.01). The -258G/x92Thr/Thr haplotype, compared with the other groups, had lower TSH values at 60  min (P<0.03). No differences were observed between genotypes in baseline TH levels.

CONCLUSIONS

The -258G/x DIO2 polymorphism variant is associated with a decreased rate of acute TSH-stimulated FT(4) secretion with a normal T(3) release from the thyroid gland consistent with a shift in the reaction equilibrium toward the product. These data indicate that the -258G DIO2 polymorphism causes changes in the pattern of hormone secretion. These findings are a proof of concept that common polymorphisms in DIO2 can subtly affect the circulating levels of TH and might modulate the TH homeostasis.

摘要

目的

2 型脱碘酶基因(DIO2)多态性与垂体-甲状腺轴稳态的变化有关。-258A/G(SNP rs12885300)多态性与酶活性增加有关,但数据存在矛盾。为了描述-258A/G 多态性对甲状腺内甲状腺素(T4)向三碘甲状腺原氨酸(T3)转化和甲状腺激素(TH)分泌模式的影响,我们研究了急性、TRH 介导、TSH 刺激甲状腺的作用。

设计

回顾性分析。

方法

研究了 45 名健康志愿者对 500μg 静脉注射 TRH 反应的 TH 分泌情况。

结果

26 名受试者(16 名女性和 10 名男性,32.8±10.4 岁)为原始(-258A/A)等位基因纯合子,19 名(11 名女性和 8 名男性,31.1±10.9 岁)为(-258G/x)变体携带者。虽然 TSH 和 T3 水平的峰值无差异,但携带-258G/x 等位基因的个体显示游离 T4(FT4)的上升幅度较低(P<0.01)。与其他组相比,-258G/x92Thr/Thr 单倍型在 60 分钟时 TSH 值较低(P<0.03)。基因型之间的基础 TH 水平无差异。

结论

-258G/x DIO2 多态性变异与急性 TSH 刺激 FT4 分泌率降低有关,甲状腺中 T3 释放正常,表明反应平衡向产物方向移动。这些数据表明,-258G DIO2 多态性导致激素分泌模式的变化。这些发现证明了 DIO2 中的常见多态性可以微妙地影响 TH 的循环水平,并可能调节 TH 的稳态。